Abstract
Neuen BL, Oshima M, Agarwal R, et al. Sodium-glucose cotransporter 2 inhibitors and risk of hyperkalemia in people with type 2 diabetes: a meta-analysis of individual participant data from randomized, controlled trials. Circulation. 2022;145:1460-70. 35394821.
MeSH terms
-
Diabetes Mellitus, Type 2* / complications
-
Diabetes Mellitus, Type 2* / drug therapy
-
Glucose
-
Humans
-
Hyperkalemia* / chemically induced
-
Hypokalemia* / chemically induced
-
Sodium
-
Sodium-Glucose Transporter 2
-
Sodium-Glucose Transporter 2 Inhibitors* / adverse effects
Substances
-
Sodium-Glucose Transporter 2
-
Sodium-Glucose Transporter 2 Inhibitors
-
Sodium
-
Glucose